{
    "clinical_study": {
        "@rank": "77117", 
        "arm_group": [
            {
                "arm_group_label": "Chlorhexidine", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Polyhexamethylene biguanide", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Treatments for the macroscopic or pathologic lesions caused by HPV infection can be\n      classified as topical, surgical, destructive, or immunomodulatory. Post surgical treatments\n      generally consist of analgesic, anti-inflammatory and topical antimicrobial agents to reduce\n      the risk of local infections.\n\n      The aim of this study is to compare the efficacy and safety of polyhexamethylene\n      biguanide-based vaginal suppositories to a similar chlorhexidine-based treatment, in the\n      post recovery regimen after surgical treatment of cervical lesions.\n\n      Women who underwent to CO2 laser therapy for cervical lesions are randomly assigned to\n      receive 10 days of antiseptic treatment with chlorhexidine digluconate vaginal\n      suppositories, or polyhexamethylene biguanide vaginal suppositories (Monogin\u00ae / BiguanelleTM\n      vaginal suppositories, Lo.Li.Pharma, Italy). A weekly follow-up check was performed for 6\n      weeks."
        }, 
        "brief_title": "Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine", 
        "condition": "Antisepsis Regimen After Surgical Treatment of HPV Infected Lesions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  positive colposcopy examination\n\n          -  positive Papanicolaou smear\n\n          -  pathological biopsy\n\n          -  physical ablation by CO2 laser therapy for a number of lesions included between 3 and\n             5\n\n        Exclusion Criteria:\n\n          -  pregnancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "firstreceived_date": "November 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740245", 
            "org_study_id": "CHX-PHMB"
        }, 
        "intervention": [
            {
                "arm_group_label": "Chlorhexidine", 
                "intervention_name": "Chlorhexidine vaginal suppositories", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Polyhexamethylene biguanide", 
                "intervention_name": "Polyhexamethylene biguanide vaginal suppositories", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chlorhexidine", 
                "Chlorhexidine gluconate", 
                "Polyhexamethylene biguanide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Laser therapy", 
            "Cervical lesions", 
            "Polyhexamethylene biguanide", 
            "Chlorhexidine"
        ], 
        "lastchanged_date": "November 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00132"
                }, 
                "name": "AGUNCO"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health"
        }, 
        "phase": "Phase 4", 
        "primary_outcome": [
            {
                "description": "Diagnosis of eventual bacterial infection is performed according to Amsel's criteria", 
                "measure": "Bacterial vaginosis", 
                "time_frame": "After three weeks by the day of the laser treatment"
            }, 
            {
                "description": "Visual scoring was assessed depending on the grade of the defect (from 1 to 3)", 
                "measure": "Change from baseline bleeding at 6 weeks", 
                "time_frame": "At weekly intervals by the day of laser treatment"
            }, 
            {
                "description": "Visual scoring for healing is assessed depending on the grade of the defect (from 1 to 3)", 
                "measure": "Change from baseline healing process at 6 weeks", 
                "time_frame": "At weekly intervals by the day of laser treatment"
            }, 
            {
                "description": "Visual scoring for irritation is assessed depending on the grade of the defect (from 1 to 3)", 
                "measure": "Change from baseline irritation status at 6 weeks", 
                "time_frame": "At weekly intervals by the day of laser treatment"
            }, 
            {
                "description": "Diagnosis is performed according to the Amsel's criteria", 
                "measure": "Bacterial vaginosis", 
                "time_frame": "After six weeks by the day of laser treatment"
            }
        ], 
        "reference": [
            {
                "PMID": "12353208", 
                "citation": "Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002 Oct 15;35(Suppl 2):S210-24."
            }, 
            {
                "PMID": "20829657", 
                "citation": "Kaehn K. Polihexanide: a safe and highly effective biocide. Skin Pharmacol Physiol. 2010;23 Suppl:7-16. Epub 2010 Sep 8. Review."
            }, 
            {
                "PMID": "20551215", 
                "citation": "Koburger T, H\u00fcbner NO, Braun M, Siebert J, Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother. 2010 Aug;65(8):1712-9. Epub 2010 Jun 15."
            }, 
            {
                "PMID": "18364400", 
                "citation": "M\u00fcller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother. 2008 Jun;61(6):1281-7. Epub 2008 Mar 25."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740245"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AGUNCO Obstetrics and Gynecology Centre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGUNCO Obstetrics and Gynecology Centre", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "June 2012"
    }
}